190 related articles for article (PubMed ID: 34911878)
21. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy.
Wen YF; Cheng TT; Chen XL; Huang WJ; Peng HH; Zhou TC; Lin XD; Zeng LS
PLoS One; 2018; 13(10):e0204334. PubMed ID: 30303986
[TBL] [Abstract][Full Text] [Related]
22. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.
Onal C; Yildirim BA; Guler OC; Mertsoylu H
Int J Gynecol Cancer; 2018 Oct; 28(8):1553-1559. PubMed ID: 30247248
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
25. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
26. Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer: Analysis by Radiation Phase and Histologic Type.
Kang JH; Cho WK; Yeo HJ; Jeong SY; Noh JJ; Shim JI; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Park W; Choi CH
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33126569
[TBL] [Abstract][Full Text] [Related]
27. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
29. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 expression and prognosis in definitive radiotherapy patients with neuroendocrine cervical carcinoma.
Li H; Li X; Yang M; Su H; Zhang J; Hu C; Sun Y; Hu D; Chen L
J Clin Transl Res; 2023 Aug; 9(4):272-281. PubMed ID: 37593242
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
[TBL] [Abstract][Full Text] [Related]
33. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma.
Yang S; Gao Y; Sun J; Xia B; Liu T; Zhang H; Li Q; Xiao M; Zhang Y
Tumour Biol; 2015 Jun; 36(6):4349-56. PubMed ID: 25874487
[TBL] [Abstract][Full Text] [Related]
35. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
36. MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.
Laliscia C; Gadducci A; Mattioni R; Orlandi F; Giusti S; Barcellini A; Gabelloni M; Morganti R; Neri E; Paiar F
Tumori; 2022 Aug; 108(4):376-385. PubMed ID: 34235995
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
38. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
